Get the Stockscreener App
6.43
3.02%
-0.20
After Hours:
6.43
Anbio Biotechnology stock is traded at $6.43, with a volume of 38,826.
It is down -3.02% in the last 24 hours and up +4.05% over the past month.
Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.
See More
Previous Close:
$6.63
Open:
$7.2
24h Volume:
38,826
Relative Volume:
0.47
Market Cap:
$282.22M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
+0.00%
1M Performance:
+4.05%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$6.40
$7.20
1-Week Range:
$6.24
$7.20
52-Week Range:
$5.60
$7.82
Anbio Biotechnology Stock (NNNN) Company Profile
Name
Anbio Biotechnology
Sector
Industry
Phone
-
Address
-
Compare NNNN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NNNN
Anbio Biotechnology
|
6.43 | 282.22M | 0 | 0 | 0 | 0.00 |
|
ISRG
Intuitive Surgical Inc
|
536.51 | 189.75B | 8.71B | 2.48B | 1.75B | 6.82 |
|
ALC
Alcon Inc
|
95.75 | 48.62B | 9.91B | 1.02B | 665.00M | 2.05 |
|
BDX
Becton Dickinson Co
|
167.22 | 48.37B | 20.87B | 1.50B | 2.59B | 5.24 |
|
RMD
Resmed Inc
|
245.04 | 35.18B | 5.02B | 1.31B | 1.56B | 8.91 |
|
COO
The Cooper Companies, Inc.
|
82.27 | 16.46B | 3.90B | 392.30M | 288.10M | 1.95 |
Anbio Biotechnology Stock (NNNN) Latest News
Highest quarter in years as med-tech raises $8B in Q1 financings - BioWorld MedTech
Financing Quarterly Statistics, Q1 2025 - insights.citeline.com
US Market's Undiscovered Gems and 2 Other Promising Small Caps - Yahoo Finance
Uncovering Hidden Opportunities In US With These 3 Undiscovered Gems - Yahoo Finance
US Market's Undiscovered Gems Featuring ZJK Industrial And 2 More Small Caps - simplywall.st
US Undiscovered Gems to Explore in April 2025 - Yahoo Finance
US Undiscovered Gems To Explore In April 2025 - Yahoo Finance
Undiscovered Gems in the US Market for April 2025 - simplywall.st
US Market's Undiscovered Gems for April 2025 - simplywall.st
Exploring US Undiscovered Gems In April 2025 - simplywall.st
Discovering 3 US Undiscovered Gems with Strong Potential - simplywall.st
US Undiscovered Gems To Watch In April 2025 - simplywall.st
Lamb Weston Posts Better-Than-Expected Results, Joins Sanofi And Other Big Stocks Moving Higher On Thursday - Benzinga
Discovering US Undiscovered Gems In April 2025 - simplywall.st
Discovering 3 Undiscovered Gems In The US Market - simplywall.st
US Market Undiscovered Gems To Explore In March 2025 - simplywall.st
US Market's Top 3 Undiscovered Gems With Strong Potential - simplywall.st
Discovering US Undiscovered Gems in March 2025 - Simply Wall St
US Market's Top 3 Undiscovered Gems with Strong Fundamentals - Simply Wall St
Uncovering 3 Undiscovered Gems In The US Market - Simply Wall St
US Market's Undiscovered Gems for March 2025 - Simply Wall St
IPO Roundup: Advanced Biomed, Brag House Holdings and more - MSN
Amaran Biotech Signs MOU with Nippon Fine Chemical - GlobeNewswire Inc.
Is the IPO Market Shutting Down? - Cabot Wealth Network
Kestra Medical ups IPO target to $150M - BioWorld Online
Unlocking Anbio's IPO: A Pivotal Shift in Global Diagnostics! - Mi Valle
U.S. IPO Weekly Recap: IPO Calendar Slows Down With Small Listings - Seeking Alpha
IPO NewsUS IPO Weekly Recap: IPO calendar slows down with small listings - Renaissance Capital
Undiscovered Gems In The US Featuring Anbio Biotechnology And 2 Other Small Caps - Yahoo Finance
Fresh Biotech Player Enters Nasdaq: Will Anbio's $8M IPO Fuel Its Global Expansion? - Stock Titan
Anbio Biotechnology's IPO opens up 5% By Investing.com - Investing.com South Africa
Anbio Biotechnology’s IPO opens up 5% By Investing.com - Investing.com Australia
Anbio Biotechnology Share Price | NASDAQ: NNNN Stock - Investing.com UK
IPO Roundup: Anbio Biotechnology, Wellgistics Health and more - MSN
Anbio Biotechnology’s IPO Set to Revolutionize Global Diagnostics - Mi Valle
NNNNANBIO BIOTECHNOLOGY Latest Stock News & Market Updates - Stock Titan
Anbio Biotechnology to Showcase Cutting-Edge Diagnostic Solutions at 2025 Medlab Middle East - PR Newswire
Anbio Biotechnology Unveils Dry Chemiluminescence Immunoassay (CLIA) Solution: Redefining Diagnostic Precision and Efficiency - PR Newswire
Anbio Biotechnology Pursues U.S. IPO For Its IVD Products Launch - Seeking Alpha
NNNN IPO NewsGermany-based diagnostics products developer Anbio Biotechnology files for a $9 million US IPO - Renaissance Capital
Anbio Biotechnology Unveils Comprehensive In-Vitro-Diagnostics Solutions at ADLM 2024 - PR Newswire
Enzyme Immunoassay Market Size to Hit USD 26.55 Billion by 2033 - BioSpace
Anbio Biotechnology to Showcase at ADLM 2024 with Evolved In Vitro Diagnostic Solutions - PR Newswire
Anbio advances POC testing with new FIA analyzer - SelectScience
Anbio Biotechnology to Showcase ABO & Rhd Blood Grouping Kit at Medlab Middle East 2024 - PR Newswire
Anbio Biotechnology to Present at Medlab Middle East on February 5th, 2024. - PR Newswire
Anbio Biotechnology Made a Successful First Presence at AACC Middle East 2023 - PR Newswire
Anbio Biotechnology made a successful first presence at AACC Middle East 2023 - BioSpace
Anbio Biotechnology Made a Successful Presence at Medic East Africa 2023 - PR Newswire
Handheld Analyzer Uses LAMP Diagnostic Technique for Rapid, Point-of-Care Testing - hospimedica.com
Anbio Biotechnology Highlights the Future of Diagnostic Solutions at AACC 2023 - PR Newswire
Anbio Biotechnology Stock (NNNN) Financials Data
There is no financial data for Anbio Biotechnology (NNNN). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
5.40%
0.78%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):